These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8828766)

  • 21. Effect of methylprednisolone on complement activation during heparin neutralization.
    Loubser PG
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):23-7. PubMed ID: 9007666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O; Fosse E; Dregelid E; Brockmeier V; Andersson C; Høgåsen K; Venge P; Mollnes TE; Kierulf P
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation.
    Korn RL; Fisher CA; Livingston ER; Stenach N; Fishman SJ; Jeevanadam V; Addonizio VP
    J Thorac Cardiovasc Surg; 1996 May; 111(5):1073-84. PubMed ID: 8622305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
    Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
    Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.
    Videm V; Svennevig JL; Fosse E; Semb G; Osterud A; Mollnes TE
    J Thorac Cardiovasc Surg; 1992 Apr; 103(4):806-13. PubMed ID: 1548925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
    Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
    Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig.
    Nilsson L; Storm KE; Thelin S; Bagge L; Hultman J; Thorelius J; Nilsson U
    Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population.
    Videm V; Mollnes TE; Fosse E; Mohr B; Bergh K; Hagve TA; Aasen AO; Svennevig JL
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):794-802. PubMed ID: 10096976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface.
    De Somer F; François K; van Oeveren W; Poelaert J; De Wolf D; Ebels T; Van Nooten G
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):602-6. PubMed ID: 11053824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit.
    Lowson SM; Hassan HM; Rich GF
    Anesth Analg; 1999 Dec; 89(6):1360-5. PubMed ID: 10589608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-coated bypass circuits reduce pulmonary injury.
    Redmond JM; Gillinov AM; Stuart RS; Zehr KJ; Winkelstein JA; Herskowitz A; Cameron DE; Baumgartner WA
    Ann Thorac Surg; 1993 Sep; 56(3):474-8; discussion 479. PubMed ID: 8104392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
    Kagisaki K; Masai T; Kadoba K; Sawa Y; Nomura F; Fukushima N; Ichikawa H; Ohata T; Suzuki K; Taketani S; Matsuda H
    Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of surface coating on platelet count drop during cardiopulmonary bypass.
    Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Gustafson PA
    Perfusion; 1999 May; 14(3):195-200. PubMed ID: 10411249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators.
    de Vroege R; van Oeveren W; van Klarenbosch J; Stooker W; Huybregts MAJM; Hack CE; van Barneveld L; Eijsman L; Wildevuur CRH
    Anesth Analg; 2004 Jun; 98(6):1586-1594. PubMed ID: 15155310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion.
    Hayashi Y; Sawa Y; Hirata N; Nishimura M; Ueda H; Naka Y; Yamaguchi T; Ohtake S; Matsuda H
    J Card Surg; 2002; 17(6):477-84. PubMed ID: 12643456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.